首页>
外国专利>
CHINOLIN UREA DERIVATIVES FOR THE TREATMENT OF DENTAL SYNDROME AND BRAIN DAMAGE CAUSED BY DENTAL SYNDROME
CHINOLIN UREA DERIVATIVES FOR THE TREATMENT OF DENTAL SYNDROME AND BRAIN DAMAGE CAUSED BY DENTAL SYNDROME
展开▼
机译:甲壳素尿素衍生物治疗牙科综合症及牙科综合症引起的脑损伤
展开▼
页面导航
摘要
著录项
相似文献
摘要
Compounds, compositions and method for ameliorating alcohol or drug dependency withdrawal syndromes and withdrawal-induced brain damage are disclosed. In particular, a series of N-substituted-4-ureido-5,7-dihalo-2-carboxy quinoline compounds are disclosed having combined properties as antagonists of voltage-sensitive sodium channels (VSNaC) and as selective competitive antagonists at the strychnine-intensive glycine site of N-methyl-D-aspartate (NMDA) receptors. The disclosed compounds prevent or reduce the signs and symptoms of neurohyperexcitability and particularly the neurohyperexcitability associated with withdrawal syndrome manifested by patients upon withdrawal from chronic use of dependence inducing agents (e.g, ethanol, barbiturates, opiates etc.). The combined actions of the disclosed compounds on VSNaC and NMDA receptors also impart properties to these compounds that are important in preventing and reducing excitotoxic neurodegeneration and reducing anxiety without the undesirable CNS depressant side-effects of agents hitherto employed for these purposes.
展开▼